semaglutide bmi 26 Prescribing for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study High-Dose Semaglutide (Up to 16

FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized

Sanofi Position: Has historically worked in the GLP-1 space (with drugs like liraglutide, lixisenatide) and is now focusing on metabolic disease innovation and new partnerships

Evans DA, Bennett DA, Wilson RS, et al

Weve represented individual and community plaintiffs who resided in more than a dozen states